ArticleClinical kidney journal2022

Immunogenicity, reactogenicity and breakthrough infections after two doses of the inactivated CoronaVac vaccine among patients on dialysis: phase 4 study.

José Medina-Pestana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.